Autoimmune Diseases

Autoimmune diseases develop when the immune system wrongly identifies healthy tissues as dangerous foreign bodies.
At Biond , we study the different immunological pathways that trigger these uncontrolled immune activation pathways and develop specific drugs to counter this ‘self-destruction’ tendency, so that the body’s immune system can be reconfigured to its normal state of self-protection
BION 404 – a drug candidate for autoimmunity which mimics the regulatory activity of regulatory T cells (Tregs) thus suppressing the activity of autoreactive immune cells.